Chemoinformaics analysis of Quercetin-3-O-?-Lrhamnosyl-(1 ? 2)-?-galactoside
Molecular Weight | 610.521 | nRot | 6 |
Heavy Atom Molecular Weight | 580.281 | nRig | 30 |
Exact Molecular Weight | 610.153 | nRing | 5 |
Solubility: LogS | -3.917 | nHRing | 3 |
Solubility: LogP | -0.644 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 16 | No. of Arom Bond | 17 |
nHA | 16 | APOL | 77.9258 |
nHD | 10 | BPOL | 39.6442 |
QED | 0.14 |
Synth | 4.777 |
Natural Product Likeliness | 2.238 |
NR-PPAR-gamma | 0.943 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.966 |
HIA | 0.932 |
CACO-2 | -6.349 |
MDCK | 0.0000425 |
BBB | 0.13 |
PPB | 0.833497 |
VDSS | 0.749 |
FU | 0.200944 |
CYP1A2-inh | 0.013 |
CYP1A2-sub | 0.024 |
CYP2c19-inh | 0.009 |
CYP2c19-sub | 0.05 |
CYP2c9-inh | 0.002 |
CYP2c9-sub | 0.177 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.153 |
CYP3a4-inh | 0.017 |
CYP3a4-sub | 0.005 |
CL | 1.465 |
T12 | 0.589 |
hERG | 0.01 |
Ames | 0.787 |
ROA | 0.061 |
SkinSen | 0.033 |
Carcinogencity | 0.063 |
EI | 0.007 |
Respiratory | 0.015 |
NR-Aromatase | 0.923 |
Antiviral | Yes |
Prediction | 0.795319 |